Chemical Carcinogens & Dna: Volume 2

219 Pages·1979·15.863 MB·\219

by  Philip L. Grover (Editor)

Chemical
Carcinogens
and DNA
Volume II
Editor
Philip L. Grover
Chester Beatty Research Institute
Institute of Cancer Research
Royal Cancer Hospital
London, England
Boca Raton London New York
CRC Press is an imprint of the
Taylor & Francis Group, an informa business
CRC Press
Taylor & Francis Group
6000 Broken Sound Parkway NW, Suite 300
Boca Raton, FL 33487-2742
Reissued 2018 by CRC Press
© 1979 by Taylor & Francis Group, LLC
CRC Press is an imprint of Taylor & Francis Group, an lnforma business
No claim to original U.S. Government works
This book contains information obtained from authentic and highly regarded sources. Reason-able
efforts have been made to publish reliable data and information, but the author and publisher cannot
assume responsibility for the validity of all materials or the consequences of their use. The authors and
publishers have attempted to trace the copyright holders of all material reproduced in this publication
and apologize to copyright holders if permission to publish in this form has not been obtained. If any
copyright material has not been acknowledged please write and let us know so we may rectify in any
future reprint.
Except as permitted under U.S. Copyright Law, no part of this book may be reprinted, reproduced,
transmitted, or utilized in any form by any electronic, mechanical, or other means, now known or
hereafter invented, including photocopying, microfilming, and recording, or in any information storage
or retrieval system, without written permission from the publishers.
For permission to photocopy or use material electronically from this work, please access www.
copyright.com (http://www.copyright.com/) or contact the Copyright Clearance Center, Inc. (CCC),
222 Rosewood Drive, Danvers, MA 01923, 978-750-8400. CCC is a not-for-profit organization that
provides licenses and registration for a variety of users. For organizations that have been granted a
photocopy license by the CCC, a separate system of payment has been arranged.
Trademark Notice: Product or corporate names may be trademarks or registered trademarks, and are
used only for identification and explanation without intent to infringe.
A Library of Congress record exists under LC control number:
Publisher's Note
The publisher has gone to great lengths to ensure the quality of this reprint but points out that some
imperfections in the original copies may be apparent.
Disclaimer
The publisher has made every effort to trace copyright holders and welcomes correspondence from those
they have been unable to contact.
ISBN 13: 978-0-367-20289-7 (hbk)
ISBN 13: 978-0-429-26069-8 (ebk)
Visit the Taylor & Francis Web site at http://www.taylorandfrancis.com and the
CRC Press Web site at http://www.crcpress.com
PREFACE
Since so little is known in molecular terms about the organization of eukaryotic cells
and the homeostatic mechanisms that control them, it is not very surprising that the
changes that are involved in the acquisition of malignancy are not understood either.
It is, however, generally accepted that chemical carcinogens exert their effects through
initial reactions with specific targets within the cell. The nature of these targets also
remains unknown but, partly because of correlations between mutagenicity and carcin-
ogenicity and partly because of the simplistic appeal of the somatic mutation hypoth-
esis, reactions of chemical carcinogens with nucleic acids, particularly DNA, continue
to receive much attention.
These two volumes represent an attempt to make an up-to-date appraisal of chemical
carcinogens from the point of view of their effects on DNA and the subject matter is
arranged in a sequence. The opening contributions deal with extents to which carcino-
gens react with DNA and with the formation and detection of DNA-carcinogen ad-
ducts and these are followed by more specialized chapters dealing with the activation
of particular types of chemical carcinogens and their reactions with DNA. The later
contributions cover the conformational changes induced in nucleic acids by chemical
carcinogens and deal with the mechanisms by which these chemical reactions may be
translated, either directly or indirectly, into biological effects that include mutagenesis
and carcinogenesis.
P. L. Grover
March 1978
THE EDITOR
Philip L. Grover, D.Sc, is a Senior Scientist on the staff of the Chester Beatty
Research Institute, Institute of Cancer Research, London, England.
Dr. Grover graduated from the University of London in 1956 and subsequently
obained M.Sc. and Ph.D. degrees for research on detoxication reactions. He joined
the scientific staff of the Chester Beatty Research Institute in 1959 where he has
worked, largely in collaboration with Dr. Peter Sims, on the metabolic activation of
the carcinogenic polycyclic hydrocarbons. He was awarded a D.Sc. by the University
of London in 1977.
CONTRIBUTORS
W. M. Baird, Ph.D. E. Kriek, Ph.D.
Associate Professor Research Biochemist and Chief
The Wistar Institute Division of Chemical Carcinogenesis
Philadelphia, Pennsylvania The Netherlands Cancer Institute
Amsterdam, The Netherlands
C. C. Chang, Ph.D.
Assistant Professor
P. D. Lawley, D.Sc.
Department of Human Development
Senior Lecturer
College of Human Medicine
Pollards Wood Research Station
Michigan State University
Institute of Cancer Research
East Lansing, Michigan
Bucks, United Kingdom
C. C. J. Culvenor, Ph.D., D.Sc.
Chief Research Scientist V. M. Maher, Ph.D.
CSIRO Associate Professor
Division of Animal Health Department of Microbiology and
Animal Health Research Laboratory Public Health and Department of
Victoria, Australia Biochemistry
and
M. Duquesne, Ph.D. Co-Director
Professor Carcinogenesis Laboratory-Fee Hall
Department of Physics Michigan State University
University of Paris and Institut Curie East Lansing, Michigan
Paris, France
G. P. Margison, Ph.D.
R. C. Garner, Ph.D.
Scientific Officer
Senior Lecturer
Paterson Laboratories
Cancer Research Unit
Christie Hospital and Holt Radium
University of York
Institute
York, United Kingdom
Manchester, United Kingdom
M. H. L. Green, Ph.D.
Scientist H. W. J. Marquardt, M.D.
MRC Cell Mutation Unit Associate Member
University of Sussex Sloan-Kettering Institute for Cancer
Brighton, United Kingdom Research
New York, New York
D. Grunberger, Ph.D. and
Associate Professsor Associate Professor
College of Physicians and Surgeons Department of Pharmacology
Institute of Cancer Research Sloan-Kettering Division
Columbia University Graduate School of Medical Sciences
New York, New York Cornell University
New York, New York
M. V. Jago, Ph.D.
Principal Research Scientist C. N. Martin, Ph.D.
CSIRO Research Fellow
Division of Animal Health Cancer Research Unit
Animal Health Research Laboratory University of York
Victoria, Australia York, United Kingdom
J. J. McCormick, Ph.D. J. E. Trosko, Ph.D.
Associate Professor Professor
Department of Microbiology and Department of Human Development
Public Health and Department of College of Human Medicine
Biochemistry Michigan State University
and East Lansing, Michigan
Co-Director
Carcinogenesis Laboratory-Fee Hall
Michigan State University
P. Vigny, Ph.D.
East Lansing, Michigan
Associate Professor
Department of Physics
P. J. O'Connor, Ph.D.
University of Paris and Institut Curie
Senior Research Officer
Paris, France
Paterson Laboratories
Christie Hospital and Holt Radium
Institute
I. B. Weinstein, M.D.
Manchester, United Kingdom
Professor
College of Physicians and Surgeons
D. H. Phillips, Ph.D.
Division of Environmental Sciences and
Post-doctoral Fellow
Institute of Cancer Research
McArdle Laboratory For Cancer
Columbia University
Research
New York, New York
University of Wisconsin
Madison, Wisconsin
P. Sims, Ph.D., D.Sc. J. G. Westra, Ph.D.
Reader in Biochemistry Research Chemist
Institute of Cancer Research Division of Chemical Carcinogenesis
Chester Beatty Research Institute The Netherlands Cancer Institute
London, United Kingdom Amsterdam, The Netherlands
TABLE OF CONTENTS
VOLUME I
Chapter 1
Approaches to Chemical Dosimetry in Mutagenesis and Carcinogenesis: The Relevance
of Reactions of Chemical Mutagens and Carcinogens with DNA 1
P. D. Lawley
Chapter 2
In Vitro Modification of Nucleic Acids by Indirect-Acting Chemical Carcinogens .. .37
P. L. Grover
Chapter 3
The Use of Radioactive Carcinogens to Detect DNA Modifications 59
W. M. Baird
Chapter 4
Fluorimetric Detection of DNA-Carcinogen Complexes 85
P. Vigny and M. Duquesne
Chapter 5
Nucleic Acid Modification by N-Nitroso Compounds Ill
G. P. Margison and P. J. O'Connor
Chapter 6
Carcinogenic Plant Products and DNA 161
C. C. J. Culvenor and M. V. Jago
Chapter 7
Fungal Toxins, Aflatoxins, and Nucleic Acids 187
R. C. Garner and C. N. Martin
Index 227
VOLUME II
Chapter 1
Metabolic Activation of Aromatic Amines and Amides and Interactions with Nucleic
Acids 1
E. Kriek and J. G. Westra
Chapter 2
Polycycfíc Aromatic Hydrocarbon Metabolites: Their Reactions with Nucleic
Acids 29
D. H. Phillips and P. Sims
Chapter 3
Conformational Changes in Nucleic Acids Modified by Chemical Carcinogens 59
D. Grunberger and I. B. Weinstein
Chapter 4
Mutagenic Consequences of Chemical Reaction with DNA 95
M. H. L. Green
Chapter 5
DNA Repair and Carcinogenesis 133
V. M. Maher and J. J. McCormick
Chapter 6
DNA — The Critical Cellular Target in Chemical Carcinogenesis? 159
H. W. J. Marquardt
Chapter 7
Chemical Carcinogenesis as a Consequence of Alterations in the Structure and-
Function of DNA 181
J. E. Trosko and C. C. Chang
Index 201
1
Chapter 1
METABOLIC ACTIVATION OF AROMATIC AMINES AND AMIDES
AND INTERACTIONS WITH NUCLEIC ACIDS
E. Kriek and J. G. Westra
TABLE OF CONTENTS
I. Introduction 2
II. Metabolic Activation Reactions of Aromatic Amines and Amides 3
A. N-oxidation to Hydroxamic Acids 3
B. Esterification Reactions of Arylhydroxamic Acids 4
1. O-Glucuronides 4
2. O-Acetates 5
3. O-Sulfates 6
C. Pathways of Formation of Arylhydroxylamines 7
1. Enzymic Deacetylation of Arylhydroxamic Acids 7
2. N-oxidation of Arylamines 7
3. Reduction of Nitro Compounds 8
D. Esterification Reactions of Arylhydroxylamines 9
1. O-Acetates 9
2. JV-Glucuronides 10
E. Peroxidase or Free Radical Activation 10
III. Interaction with Nucleic Acids 11
A. Sites of Covalent Reaction 12
1. 2-Acetylaminofluorene 12
2. 4-Acetylaminobiphenyl 14
3. 4-Acetylamino-4'-fluorobiphenyl 14
4. 2-Acetylaminophenanthrene 15
5. N-Methyl-4-aminoazobenzene 15
6. Other Aromatic Amines and Amides 17
B. Mechanistic Aspects of the Formation of Covalent Bonds 18
C. Distribution of Covalently Bound Aromatic Amine Residues in DNA . 19
D. Other Modes of Interaction 21
Acknowledgments 22
References 23